2QM Stock Overview
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Medigus Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$2.32 |
52 Week High | US$6.65 |
52 Week Low | US$2.28 |
Beta | 1.36 |
1 Month Change | -10.77% |
3 Month Change | -27.95% |
1 Year Change | -39.58% |
3 Year Change | -91.45% |
5 Year Change | -93.89% |
Change since IPO | -93.84% |
Recent News & Updates
Recent updates
Shareholder Returns
2QM | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -1.7% | -0.6% | 1.6% |
1Y | -39.6% | 2.8% | 6.4% |
Return vs Industry: 2QM underperformed the German Medical Equipment industry which returned 2.9% over the past year.
Return vs Market: 2QM underperformed the German Market which returned 6.4% over the past year.
Price Volatility
2QM volatility | |
---|---|
2QM Average Weekly Movement | 7.1% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2QM's share price has been volatile over the past 3 months.
Volatility Over Time: 2QM's weekly volatility has decreased from 12% to 7% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 77 | Liron Carmel | https://www.medigus.com |
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.
Medigus Ltd. Fundamentals Summary
2QM fundamental statistics | |
---|---|
Market cap | €4.79m |
Earnings (TTM) | -€13.31m |
Revenue (TTM) | €101.75m |
0.0x
P/S Ratio-0.4x
P/E RatioIs 2QM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2QM income statement (TTM) | |
---|---|
Revenue | US$110.28m |
Cost of Revenue | US$93.82m |
Gross Profit | US$16.46m |
Other Expenses | US$30.89m |
Earnings | -US$14.42m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -7.61 |
Gross Margin | 14.93% |
Net Profit Margin | -13.08% |
Debt/Equity Ratio | 24.7% |
How did 2QM perform over the long term?
See historical performance and comparison